What is the recommended dose of gentamicin (aminoglycoside antibiotic) for an open fracture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Gentamicin Dosing for Open Fractures

For open fractures, administer gentamicin 5-6 mg/kg IV once daily in combination with cefazolin 1-2 g every 8 hours, continuing for 48 hours after definitive wound closure. 1, 2

Recommended Dosing Regimen

  • Once-daily dosing: 5-6 mg/kg IV as a single daily dose 1, 2

    • This regimen has been specifically validated in Gustilo Grade II and III open fractures 1
    • A prospective randomized trial demonstrated that 6 mg/kg once daily was equally effective as divided dosing (5 mg/kg divided twice daily) for infection prevention 1
  • Duration: Continue until 48 hours after definitive wound closure 2

    • Typical duration is 2-5 days depending on timing of wound closure 2
  • Combination therapy is mandatory: Always administer with cefazolin 1 g every 8 hours 1, 2

    • Gentamicin should never be used as monotherapy for open fractures 1

Dosing in Patients with Normal Renal Function

  • Standard FDA-approved dosing for serious infections: 3 mg/kg/day divided every 8 hours 3
  • For life-threatening infections: Up to 5 mg/kg/day in divided doses 3
  • However, the orthopedic trauma literature supports higher once-daily dosing (5-6 mg/kg) specifically for open fractures 1, 2

Critical Monitoring Parameters

  • Peak levels (30-60 minutes post-infusion): Target 4-6 mcg/mL, never exceed 12 mcg/mL 3
  • Trough levels (just before next dose): Target <1-2 mcg/mL 3
  • Monitor BUN and creatinine daily during therapy 2
  • Query patient daily for signs of ototoxicity (tinnitus, vertigo, hearing loss) 2

Dose Adjustments for Renal Impairment

Critical caveat: Serum creatinine alone may not accurately reflect renal function in certain populations 4

  • If creatinine clearance <50 mL/min: Reduce dose and extend dosing interval 5
  • If creatinine clearance <20 mL/min: Avoid once-daily regimens entirely 5
  • For patients with impaired renal function, calculate estimated creatinine clearance based on age, sex, weight, and actual creatinine 5, 4
  • Even the first dose should be adjusted in high-risk patients 4

Evidence Quality and Clinical Context

The once-daily high-dose regimen (5-6 mg/kg) is supported by Level II evidence from prospective randomized trials specifically in open fractures 1. A study of 75 Gustilo Grade II and III fractures found no difference in infection rates between once-daily (6 mg/kg) versus divided dosing (5 mg/kg divided twice daily), with the added benefits of cost-efficiency and simplified administration 1. A subsequent study of 16 patients with open tibial shaft fractures using 5 mg/kg once daily showed no nephrotoxicity or ototoxicity 2.

Important distinction: The FDA label recommends lower divided dosing (3 mg/kg/day) for general serious infections 3, but orthopedic trauma-specific evidence supports higher once-daily dosing for open fractures 1, 2. This reflects the unique pharmacokinetic advantages of once-daily aminoglycoside dosing and the specific bacterial pathogens encountered in open fractures.

Common Pitfalls to Avoid

  • Do not use gentamicin monotherapy - always combine with a cephalosporin for adequate gram-positive coverage 1, 2
  • Do not rely on serum creatinine alone in special populations (spinal cord injury, elderly, low muscle mass) - calculate creatinine clearance 4
  • Do not continue beyond 48 hours after wound closure unless treating established infection 2
  • Do not use once-daily dosing for endocarditis - that indication requires divided dosing every 8 hours 6
  • Do not dose obese patients on total body weight - use lean body mass 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.